About 1 result found for searched term "Girentuximab" (0.119 seconds)
Cat.No. | Name | Target |
---|---|---|
M25289 | Girentuximab | Carbonic Anhydrase |
G250; cG250 | ||
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.